Metabolic and cardiovascular benefits and risks of 4-hydroxy guanabenz hydrochloride: α(2)-adrenoceptor and trace amine-associated receptor 1 ligand

BACKGROUND: α(2)-adrenoceptor ligands have been investigated as potential therapeutic agents for the treatment of obesity. Our previous studies have shown that guanabenz reduces the body weight of obese rats, presumably through its anorectic action. This demonstrates an additional beneficial effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotańska, Magdalena, Marcinkowska, Monika, Kuder, Kamil J., Walczak, Maria, Bednarski, Marek, Siwek, Agata, Kołaczkowski, Marcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539439/
https://www.ncbi.nlm.nih.gov/pubmed/37624466
http://dx.doi.org/10.1007/s43440-023-00518-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539439/
https://www.ncbi.nlm.nih.gov/pubmed/37624466
http://dx.doi.org/10.1007/s43440-023-00518-9

Ejemplares similares